Authorities in Gurugram have uncovered a racket involved in the manufacturing and sale of fake Mounjaro (tirzepatide) injections, used for treating diabetes and obesity. Two people have been arrested, and a nationwide alert has been issued to trace counterfeit batches.
Authorities in Gurugram have uncovered a racket involving the manufacturing and sale of counterfeit Mounjaro (tirzepatide) injections, used for treating type 2 diabetes and aiding weight loss. Two individuals have been arrested, and a nationwide alert has been issued to detect the fake injections.
Authorities in Gurugram have uncovered a racket involving the manufacturing and sale of counterfeit Mounjaro (tirzepatide) injections, used for treating type 2 diabetes and aiding weight loss, leading to the arrest of two individuals and a nationwide alert.
An independent think tank on policing has called for a multi-agency investigation into the recent unearthing of a spurious Mounjaro (tirzepatide) injection manufacturing racket in Gurugram, offering free-of-cost forensic expertise.
A new study reveals a framework using smartwatch data to detect early signs of diabetes by predicting insulin resistance, potentially enabling timely lifestyle interventions.
rediffGURU Komal Jethmalani, a nutritionist with nearly three decades of experience, suggests how to make the right diet and lifestyle choices to keep blood sugar under check.
As he chases Grand Slam success, Alexander Zverev describes the unseen routines and discipline behind playing tennis with type 1 diabetes.
Researchers are cautioning against relying solely on glycated haemoglobin (HbA1c) for diagnosing and monitoring diabetes in South Asia, especially India, due to the high prevalence of anaemia and blood disorders that can complicate the interpretation of values.
Dr Reddy's Laboratories has received approval from Health Canada to sell a generic version of the diabetes drug semaglutide, making it the first company to get market authorisation for a generic semaglutide injection in Canada and the first in a G7 country.
A vehicle carrying thousands of weight loss and diabetes injections was seized in Gurugram during a raid by the Drug Control Department.
The fast-growing GLP-1 market, propelled by lower-cost generics following patent expiry, is widening availability beyond patients with obesity and diabetes -- but also driving unsupervised, appearance-led demand, according to doctors.
Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the fast-growing diabetes and obesity market currently dominated by the likes of Novo Nordisk and Eli Lilly.
Young adults show alarming NCD trends, with high rates of obesity, prediabetes, and abnormal cholesterol levels.
Biocon aims to become the world's leading insulin company, capitalising on larger pharmaceutical rivals' strategic shift towards newer, high-margin GLP-1 diabetes therapies. The company plans to expand its insulin presence across 80 markets, focusing on value maximisation and addressing the indispensable need for insulin, particularly for Type-1 and late-stage Type-2 diabetics.
A 60-year-old murder accused allegedly committed suicide inside a jail in Jabalpur, Madhya Pradesh, on Monday morning. The undertrial prisoner, Guddu alias Raja Vishwakarma, allegedly hanged himself using a towel in the bathroom of a hospital ward in the prison where he was being treated.
'In diabetes remission, you go below a 6.5 HbA1c without medication.' 'And this happens only when you lose 10 to 15 per cent of your body weight with a good amount of lifestyle and dietary changes, exercise and sometimes medication.' 'You have to be able to sustain your HBA1C below 6.5 for at least a year without medication to say that the patient is in remission.'
India's domestic pharmaceutical market recorded its highest value growth in five quarters during Q4 FY26, driven primarily by pricing and an early indication of volume recovery, with a significant structural shift towards chronic and sub-chronic therapies.
A parliamentary panel has been informed that the prevalence of hypertension among Indian Army's junior commissioned officers and other ranks is lower than the national average, according to data up to December 31, 2023.
'One in two people tested shows high blood sugar levels.' '51.9 per cent of men and 45.43 per cent of women who tested had high blood sugar.'
Inspections conducted across 49 entities including pharmacies, wholesalers, and clinics to detect violations and misleading marketing practices.
This innovation works by stimulating our natural organs so that it can produce and maintain the insulin balance.
At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.
'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'
A new study reveals that widely used heart disease risk calculators may not accurately identify Indians at risk, potentially leading to underestimation of risk and delayed treatment.
Delhi Police have dismantled an organised interstate racket involved in manufacturing and distributing counterfeit life-saving medicines, arresting six individuals and seizing fake drugs worth approximately Rs 2 crore. The investigation also revealed a network of fake GST firms used for generating bogus invoices and laundering money.
A man was shot dead in Delhi's Preet Vihar following a parking dispute with a neighbour. The incident has left his pregnant wife and family in mourning.
'The unregulated marketing has to stop. People are getting recommendations for this from gym trainers, from marriage counsellors -- that is simply unacceptable.' ''There are many ways to lose weight -- eat less, fast, exercise, eat healthy. That is how you lose weight.'
A Delhi court has granted Amit Katyal, a businessman linked to Lalu Prasad's family, permission to travel for religious purposes and modified his bail conditions in a money laundering case.
Skipping breakfast can lead to insulin resistance and overeating later, warns rediffGURU Komal Jethmalani, a nutritionist with over 26 years of experience.
'Many policyholders do not understand that non-medical expenses, cosmetic treatments, and certain other procedures are not covered by health insurance policies.'
Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.
'Weight loss drugs can be life changing but are not without risks,' says Dr Vishnu Radhakrishnan as he explains the truth behind Ozempic and Mounjaro.
The Lancet study revealed that the HbA1c test is erroneous in populations with anemia and other hemoglobin-related deficiencies in India.
While the introduction of branded generics is likely to accelerate volumes for GLP-1 agonists, value growth may moderate because of price erosion.
While fertility does decline with age, many women have successfully delivered babies after the age of 40, notes Dr Rohan Palshetkar, consultant IVF specialist at Bloom IVF and Palshetkar Patil Nursing Home.
Burnout reduces pleasure, curiosity, and the ability to feel desire, even in healthy relationships.
Nearly one in five older Indians are affected by diabetes with many remaining unaware that they have the disease.
Anyone who has felt queasy, been sick, or had a unsettled tummy has likely tried ginger or been advised to do so. Ginger has been trusted for centuries as a gentle and reliable solution to many a medical ill.
'Everyone with a low BMI will not get Type 5 diabetes.'
A strong third-quarter (October-December/Q3) performance for 2025-26 (FY26) has helped the stock of India's largest listed pharmaceutical (pharma) company, Sun Pharmaceutical Industries, gain about 7 per cent since the start of February.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances